Selected article for: "antibody response and long term protection"

Author: Rijkers, Ger; Murk, Jean-Luc; Wintermans, Bas; Looy, Bieke van; Berge, Marcel van den; Veenemans, Jacobien; Stohr, Joep; Reusken, Chantal; Pol, Pieter van der; Reimerink, Johan
Title: Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections
  • Cord-id: yuwrr4vg
  • Document date: 2020_6_12
  • ID: yuwrr4vg
    Snippet: We determined and compared the humoral immune response in severe, hospitalized and mild, non-hospitalized COVID-19 patients. Severe patients (n=38) develop a robust antibody response to SARS-CoV-2, including IgG and IgA antibodies. The geometric mean 50% virus neutralization titer is 1:240. SARS-CoV-2 infected hospital personnel (n=24), who developed mild symptoms necessitating leave of absence, self-isolation, but not hospitalization, 75 % develop antibodies, but with low/absent virus neutraliz
    Document: We determined and compared the humoral immune response in severe, hospitalized and mild, non-hospitalized COVID-19 patients. Severe patients (n=38) develop a robust antibody response to SARS-CoV-2, including IgG and IgA antibodies. The geometric mean 50% virus neutralization titer is 1:240. SARS-CoV-2 infected hospital personnel (n=24), who developed mild symptoms necessitating leave of absence, self-isolation, but not hospitalization, 75 % develop antibodies, but with low/absent virus neutralization (60% < 1:20). While severe COVID-19 patients develop a strong antibody response, mild SARS-CoV-2 infections induce a modest antibody response. Long term monitoring will show whether these responses predict protection against future infections.

    Search related documents:
    Co phrase search for related documents
    • absence leave and low absent: 1
    • absence leave and low absent virus neutralization: 1
    • long term monitoring and low absent virus neutralization: 1